Table 1 Patient characteristics
Number (N = 242) | Percent (%) | |
|---|---|---|
Gender | ||
Males | 203 | 83.9 |
Age group | ||
≤ 40 | 14 | 5.8 |
40–50 | 80 | 33 |
50–60 | 113 | 46.7 |
> 60 | 35 | 14.5 |
Etiology | ||
HCV | 183 | 75.6 |
HBV | 34 | 14 |
HCV + HBV | 10 | 4.1 |
HBV + HDV | 5 | 2 |
Cryptogenic | 7 | 2.9 |
Others | 3 | 1.2 |
Graft to recipient weight ratio | ||
< 0.8 | 40 | 16.5 |
> 0.8 | 202 | 83.5 |
MELD score | ||
≤ 10 | 27 | 11.2 |
11–20 | 129 | 53.3 |
21–30 | 77 | 31.8 |
> 31 | 9 | 3.7 |
CTP class | ||
A | 50 | 20.7 |
B | 100 | 41.3 |
C | 92 | 38 |
Extent | ||
Within Milan | 134 | 55.4 |
Within UCSF criteria | 16 | 6.6 |
Outside UCSF criteria | 92 | 38 |
Tumor nodules | ||
1 | 118 | 48.7 |
2 | 56 | 23.1 |
3 | 18 | 7.4 |
Multiple | 50 | 20.7 |
AFP (ng/ml) (N = 232) | ||
Normal | 74 | 31.9 |
≤ 600 | 136 | 58.6 |
> 600 | 22 | 9.5 |
Preoperative treatment | ||
TACE | 54 | 22.3 |
RFA | 11 | 4.5 |
Grade | ||
Well/moderate | 163 | 67.3 |
Poor | 71 | 29.4 |
Complete response | 8 | 3.3 |
Micro vascular invasion | ||
Present | 85 | 35.1 |